Reviv3 Procare raises $448k via private placement of 1.95M shares at $0.23/share

Axil Brands, Inc.

Issued 1,947,175 shares of common stock at $0.23 per share to accredited investors.
Gross proceeds of $447,850.25; offering exempt under Rule 506(b) of Regulation D.
Outstanding shares after placement: 117,076,949 as of February 28, 2023.
Proceeds will be used for general corporate purposes; no minimum raise required.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Axil Brands, Inc. entered into Securities Purchase Agreements with accredited investors valued at $447,850.25 (effective 2023-02-23).

Action: entry
Agreement: equity purchase
Counterparty: accredited investors
Value: $447,850.25
Effective: 2023-02-23

Exact text from the filing

On February 23, 2023, Reviv3 Procare Company (the “Company”), a Delaware corporation, issued in private placements to accredited investors an aggregate of 1,947,175 shares of its common stock, par value $0.0001 per share. The securities were issued at a purchase price of $0.23 per share for aggregate gross proceeds to the Company of $447,850.25.

View on SEC.gov

Browse all material agreements →

Axil Brands, Inc. filing history →

Source: SEC EDGAR

accession 0001520138-23-000122

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.